PL1912661T3 - Prosty sposób przeszczepiania chondrocytów do wstrzyknięć do autologicznego przeszczepu chondrocytarnego - Google Patents

Prosty sposób przeszczepiania chondrocytów do wstrzyknięć do autologicznego przeszczepu chondrocytarnego

Info

Publication number
PL1912661T3
PL1912661T3 PL05809011T PL05809011T PL1912661T3 PL 1912661 T3 PL1912661 T3 PL 1912661T3 PL 05809011 T PL05809011 T PL 05809011T PL 05809011 T PL05809011 T PL 05809011T PL 1912661 T3 PL1912661 T3 PL 1912661T3
Authority
PL
Poland
Prior art keywords
chondrocyte
mixing
transplanting
syringe
injectable
Prior art date
Application number
PL05809011T
Other languages
English (en)
Inventor
Chang-Kwon Ko
Eun-Young Lee
Jeong-Yong Choi
Jae-Deog Jang
Cheong-Ho Chang
Pyoung-Min Kim
Original Assignee
Sewon Cellontech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sewon Cellontech Co Ltd filed Critical Sewon Cellontech Co Ltd
Publication of PL1912661T3 publication Critical patent/PL1912661T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
PL05809011T 2005-07-20 2005-09-23 Prosty sposób przeszczepiania chondrocytów do wstrzyknięć do autologicznego przeszczepu chondrocytarnego PL1912661T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020050066026A KR100774089B1 (ko) 2005-07-20 2005-07-20 주입형 연골세포치료제의 이식방법
PCT/KR2005/003147 WO2007011094A1 (en) 2005-07-20 2005-09-23 Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation
EP05809011A EP1912661B1 (en) 2005-07-20 2005-09-23 Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation

Publications (1)

Publication Number Publication Date
PL1912661T3 true PL1912661T3 (pl) 2011-08-31

Family

ID=37668959

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05809011T PL1912661T3 (pl) 2005-07-20 2005-09-23 Prosty sposób przeszczepiania chondrocytów do wstrzyknięć do autologicznego przeszczepu chondrocytarnego

Country Status (18)

Country Link
US (1) US20090254065A1 (pl)
EP (1) EP1912661B1 (pl)
JP (1) JP2009501605A (pl)
KR (1) KR100774089B1 (pl)
CN (1) CN101247815A (pl)
AT (1) ATE501744T1 (pl)
BR (1) BRPI0520520A2 (pl)
CY (1) CY1111563T1 (pl)
DE (1) DE602005027004D1 (pl)
DK (1) DK1912661T3 (pl)
ES (1) ES2361420T3 (pl)
HR (1) HRP20110321T1 (pl)
MX (1) MX2008000787A (pl)
PL (1) PL1912661T3 (pl)
PT (1) PT1912661E (pl)
RS (1) RS51951B (pl)
SI (1) SI1912661T1 (pl)
WO (1) WO2007011094A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101114773B1 (ko) * 2009-10-23 2012-03-05 세원셀론텍(주) 연골조직 수복용 조성물의 제조방법
CN101716382B (zh) * 2009-12-02 2015-07-15 浙江大学 一种质粒dna/纤维蛋白凝胶/聚合物三元复合支架的制备方法
KR20160129108A (ko) * 2011-04-15 2016-11-08 가톨릭대학교 산학협력단 결합조직 재생용 조성물 및 결합조직을 재생하는 방법
KR101279812B1 (ko) * 2012-05-16 2013-06-28 세원셀론텍(주) 연골조직 수복용 조성물의 제조방법
CN105255814B (zh) * 2015-10-27 2016-09-21 上海科医联创生物科技有限公司 一种用于微骨折手术的软骨诱导基质的制备方法
CN106581772B (zh) * 2016-12-02 2020-02-18 四川大学华西医院 携带G-CSF缓释系统的Fibrin-HA水凝胶及其制备方法和用途
KR20190092059A (ko) * 2018-01-30 2019-08-07 가톨릭대학교 산학협력단 연골세포, 피브리노겐, 콜라겐 또는 트롬빈을 포함하는 관절경하 수술을 위한 연골 재생용 조성물
CN113440726B (zh) * 2021-01-26 2025-07-15 南方科技大学 一种非手性磁控微型支架机器人及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US6886568B2 (en) * 1998-04-08 2005-05-03 The Johns Hopkins University Method for fabricating cell-containing implants
KR20010082172A (ko) * 1998-08-14 2001-08-29 추후제출 연골세포 이식을 위한 방법, 기구 및 물질
IL153490A0 (en) * 2000-06-29 2003-07-06 Biosyntech Canada Inc Composition and method for the repair and regeneration of cartilage and other tissues
US7931687B2 (en) * 2002-05-13 2011-04-26 Articular Engineering, Llc Tissue engineered osteochondral implant
US7316822B2 (en) * 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery
KR100531922B1 (ko) 2003-12-23 2005-11-29 주식회사 셀론텍 연골치료제 조성물 및 그 사용방법

Also Published As

Publication number Publication date
DK1912661T3 (da) 2011-06-06
CY1111563T1 (el) 2015-10-07
DE602005027004D1 (de) 2011-04-28
BRPI0520520A2 (pt) 2009-05-12
EP1912661B1 (en) 2011-03-16
CN101247815A (zh) 2008-08-20
MX2008000787A (es) 2008-04-08
PT1912661E (pt) 2011-05-25
HRP20110321T1 (hr) 2011-06-30
JP2009501605A (ja) 2009-01-22
ES2361420T3 (es) 2011-06-16
KR100774089B1 (ko) 2007-11-06
KR20070010990A (ko) 2007-01-24
ATE501744T1 (de) 2011-04-15
RS51951B (sr) 2012-02-29
EP1912661A1 (en) 2008-04-23
WO2007011094A1 (en) 2007-01-25
US20090254065A1 (en) 2009-10-08
SI1912661T1 (sl) 2011-07-29
EP1912661A4 (en) 2009-09-09

Similar Documents

Publication Publication Date Title
CY1111563T1 (el) Απλη μεθοδος μεταμοσχευσης ενεσιμων χονδροκυτταρων για αυτολογο μεταμοσχευση χονδροκυτταρων
Fennema et al. Ectopic bone formation by aggregated mesenchymal stem cells from bone marrow and adipose tissue: a comparative study
Guilak et al. 2010 Nicolas Andry Award: multipotent adult stem cells from adipose tissue for musculoskeletal tissue engineering
US8497121B2 (en) Method of obtaining viable small tissue particles and use for tissue repair
US9011929B2 (en) Composition for inducing tissue regeneration by activating platelet-rich plasma (PRP)
EP2257176B1 (en) Compositions and methods for cartilage repair
Mollon et al. The clinical status of cartilage tissue regeneration in humans
Wise et al. Comparison of uncultured marrow mononuclear cells and culture-expanded mesenchymal stem cells in 3D collagen-chitosan microbeads for orthopedic tissue engineering
Zhu et al. A photoannealed granular hydrogel facilitating hyaline cartilage regeneration via improving chondrogenic phenotype
RU2010142988A (ru) Способ и композиция для регенерации тканей с помощью стволовых или костномозговых клеток
Lalegül-Ülker et al. Encapsulation of bone marrow-MSCs in PRP-derived fibrin microbeads and preliminary evaluation in a volumetric muscle loss injury rat model: modular muscle tissue engineering
JP2005503146A5 (pl)
Sassoon et al. Skeletal muscle and bone marrow derived stromal cells: a comparison of tenocyte differentiation capabilities
MXPA04012601A (es) Medio de cultivo de celulas madre-progenitoras autologas humanas y sus aplicaciones.
de Albornoz et al. Cell therapies in tendon, ligament, and musculoskeletal system repair
Hubbell Matrix-bound growth factors in tissue repair
Chen et al. Disruption of cell‐cell contact‐mediated notch signaling via hydrogel encapsulation reduces mesenchymal stem cell chondrogenic potential: Winner of the Society for Biomaterials Student Award in the Undergraduate Category, Charlotte, NC, April 15 to 18, 2015
MY144022A (en) Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation
Mwale et al. The constitutive expression of type x collagen in mesenchymal stem cells from osteoarthritis patients is reproduced in a rabbit model of osteoarthritis
JM et al. Cartilage regeneration using a novel autologous growth factors-based matrix for full-thickness defects in sheep.
Natsir Kalla et al. Tissue Engineering for Cleft Defects: Systematic Review and Meta-Analysis. Cleft Palate Craniofac J. 2023 May 18: 10556656231175278. doi: 10.1177/10556656231175278. Epub ahead of print. PMID: 37203174.
CN117562925A (zh) 用于关节组织损伤修复的MSCs/PRP制剂组合及其制备方法和制剂盒
Aziz Regenerative Techniques in Periodontology.
Desai et al. Novel In Situ Forming Hydrogels for Cartilage Tissue Engineering
Zelenka The Effect of Bmp-13 on the Chondroinduction of Mesenchymal Stem Cells